¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 2ÀÏÂ÷ : 2021-09-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 2ÀÏÂ÷ : 2021-09-17
±³À°ÀÏÀÚ : 2021-09-17
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 5Ãþ ±×·£µåº¼·ë  
±³À°ÁÖÁ¦ : ´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 2ÀÏÂ÷
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ  
´ã´çÀÚ : ¹éÁöÀº
¿¬¶ôó : 02-3275-5335  
À̸ÞÀÏ : kshf4@kshf.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í ±³¼ö: 70,000¿ø, ÀϹÝÀÇ: 30,000¿ø, Àü°øÀÇ, °£È£»ç, 65¼¼ ÀÌ»ó, Çлý, ±âŸ(ÀÌ¿Ü ÀÇ·áÁ¾»çÀÚ): ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 09:00~09:20 Introduction of ESC (or HFA) Educational Program  Ewa Anita Jankowska(Wroclaw Medical University) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 09:20~09:35 Current Status and Future Perspective of Educational Program for Cardiologist in Korea  ¹ÚÈñ³²(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 09:35~09:50 Setting Up of Early Career as a HF Specialist  ±è°æÈñ(ÀÎõ¼¼Á¾º´¿ø) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 09:50~10:20 New HFpEF Diagnosis Concept. Is the Classiffication based on Ejection Fraction Kept on?  Andrew Coats(Univ of Warwick UK) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 10:20~10:50 Novel or Revisit of Pharmacological Treatment of HFpEF  Stefan D. Anker(Charite Campus Virchow Clinic Germany) 
Åä·Ð 09-17 ±×·£µåº¼·ë 10:50~11:10 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ09-17 ±×·£µåº¼·ë 11:10~11:20 Short Coffee Break  () 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 11:20~11:35 Practical Management of ECMO in aborted Sudden Cardiac Death  ±è¹Î¼®(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 11:35~11:50 Start ECMO in Left Heart Decompression: When, How ?  À̼±±â(ÇѸ²ÀÇ´ë) 
Åä·Ð 09-17 ±×·£µåº¼·ë 11:50~12:00 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
½Ä»ç 09-17 ±×·£µåº¼·ë 12:00~13:00 Lunch  () 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 13:00~14:00 Brightening Abstract Presentation (I)  () 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 14:00~14:15 Utilization of Marginal Donors in Heart Transplantation  Jon A Kobashigawa(Cedars-Sinai Medical Center USA) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 14:15~14:30 Current Status of Heart Transplantation and LVAD in Korea  ÃÖÁø¿À(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 14:30~14:45 The Right Ventricle and LVAD Therapy  Mandeep R Mehra(Harvard Univ. USA) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 14:45~15:00 Palliative Management in End Stage HF Patients  À̼ö¿ë(ºÎ»êÀÇ´ë) 
Åä·Ð 09-17 ±×·£µåº¼·ë 15:00~15:20 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ09-17 ±×·£µåº¼·ë 15:20~15:30 Short Coffee Break  () 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 15:30~15:45 Initial Phenotyping and Therpeutic Decision Making in HFpEF  ÃÖÁ¤Çö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 15:45~16:00 Echocardiography for CIED  ±è¿ëÁø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 16:00~16:15 Decision Making in Critically Ill Patients  ±è´ëÈñ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 16:15~16:30 The Use of Echocardiography in Post Heart Transplantation  ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë) 
Åä·Ð 09-17 ±×·£µåº¼·ë 16:30~17:00 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ09-17 ±×·£µåº¼·ë 17:00~17:10 Short Coffee Break  () 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 17:10~17:25 Gender specific HF treatment strategy  ±èÇзÉ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 17:25~17:40 RFA of atrial fibrillation and single nucleotide polymorphism  ÃÖÁ¾ÀÏ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 17:40~17:55 Role of precision medicine in pulmonary hypertension  Á¤¿íÁø(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 09-17 ±×·£µåº¼·ë 17:55~18:10 Emerging Roles of Biomarkers in Heart Failure  Á¶µ¿Çõ(¿¬¼¼¿øÁÖÀÇ´ë) 
Åä·Ð 09-17 ±×·£µåº¼·ë 18:10~18:40 Discussion  ´Ù°­»ç(´Ù¼Ò¼Ó) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 2ÀÏÂ÷ : 2021-09-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 3ÀÏÂ÷ : 2021-09-18
´ÙÀ½±Û ´ëÇѽɺÎÀüÇÐȸ Á¦43Â÷ Ãß°è Çмú´ëȸ(Heart Failure Seoul 2021) 1ÀÏÂ÷ : 2021-09-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
504 ¼­¿ï 2018³â Á¦ 9ȸ ¼­¿ï¾Æ»êº´¿ø ±¹¸³º¸°Ç¿¬±¸¿ø ¾Ë·¹¸£±âÁúȯ ¿ªÇÐ ½ÉÆ÷Áö¾ö : 2018-09-08 0 652 2018-08-22
503 °æ³² â¿ø °æ»ó´ëÇб³º´¿ø °æ³²°³¿ø³»°úÀÇ»çȸ Ãß°èÇмú´ëȸ : 2018-09-08 0 1,362 2018-08-22
502 ±¤ÁÖ Á¦169Â÷ ´ëÇѼҾưúÇÐȸ ±¤ÁÖ¡¤Àü³²Áöȸ ÇмúÁý´ãȸ : 2018-09-08 0 900 2018-08-22
501 ¼­¿ï °¡Å縯ÀÇ´ë(¼­¿ï¼º¸ðº´¿ø) 2018 ´ëÇÑ°¨¿°ÇÐȸ Àü°øÀÇ¿Í Àü¹®ÀǸ¦ À§ÇÑ Ãß°è °¨¿°ÇÐ ¿¬¼ö°­Á : 2018-09-08 0 468 2018-08-22
500 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø À¯¹æ¼ºÇü¿¬±¸È¸ 3Â÷ ½ÉÆ÷Áö¿ò : 2018-09-08 1 822 2018-08-22
499 ºÎ»ê Á¦7ȸ ºÎ¹Îº´¿ø ½½°üÀý ½ÉÆ÷Áö¾ö(´ëÇѽ½°üÀýÇÐȸ, ºÎ¹Îº´¿ø °øµ¿ÁÖ°ü) : 2018-09-08 0 1,555 2018-08-22
498 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø 2018 ¾Æ»ê ÇÙÀÇÇÐ ½ÉÆ÷Áö¾ö : 2018-09-08 0 592 2018-08-22
497 ¼­¿ï °æÈñ´ëÇб³º´¿ø 2018 KYUNG HEE SHOULDER SYMPOSIUM : 2018-09-08 0 1,500 2018-08-22
496 ´ë±¸ °æºÏ´ëÇб³º´¿ø Á¦ 3Â÷ °³¿øÀǸ¦ À§ÇÑ ´ëÇѺÎÁ¤¸ÆÇÐȸ ¿¬¼ö±³À° : 2018-09-07 0 740 2018-08-22
495 °­¿ø ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø NAFLD(non-alcoholic fatty liver disease) and Cardiometabolic Syndrome [7th Gangwon Heart Seminar 2018] : 2018-09-07 0 917 2018-08-22
494 ÀüºÏ ÀüÁÖ ¿¹¼öº´¿ø ´ëÇÑÀçÈ°ÀÇÇÐȸ È£³²Á¦ÁÖÁöȸ ÀçÈ° ½ÉÆ÷Áö¾ö : 2018-09-07 0 1,003 2018-08-22
493 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-07 0 793 2018-08-22
492 ¼­¿ï 2018³â °³¿øÀǸ¦ À§ÇÑ °­µ¿°æÈñ´ëÇб³º´¿ø ¼ÒÈ­±âÁúȯ ¿¬¼ö°­Á : 2018-09-06 0 616 2018-08-22
491 Ãæ³² ´Ü±¹´ëÇб³º´¿ø 2018³â Á¦3Â÷ ´ëÇѺ´¸®ÇÐȸ ´ëÀü¤ýÃæûÁöȸ: ÃÖ½ÅÀÇÇÐÁ¤º¸ Ư°­ ¹× º´¸®ÇÐ Áõ·Ê ¹ßÇ¥ : 2018-09-06 0 713 2018-08-22
490 ´ë±¸ ´ëÇѽŻý¾ÆÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2018-09-06 0 983 2018-08-22
1341 | 1342 | 1343 | 1344 | 1345 | 1346 | 1347 | 1348 | 1349 | 1350
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷